1	Phenotypic	phenotypic	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	functional	functional	_	_	_	_	_	_	_
4	studies	study	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	leukocytes	leukocyte	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	endometrium	endometrium	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	endometriosis	endometriosis	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	aetiology	aetiology	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	endometriosis	endometriosis	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	common	common	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	disabling	disable	_	_	_	_	_	_	_
10	disorder	disorder	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	presently	presently	_	_	_	_	_	_	_
14	unknown	unknown	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	although	although	_	_	_	_	_	_	_
17	immune	immune	_	_	_	_	_	_	_
18	dysfunction	dysfunction	_	_	_	_	_	_	_
19	could	could	_	_	_	_	_	_	_
20	allow	allow	_	_	_	_	_	_	_
21	ectopic	ectopic	_	_	_	_	_	_	_
22	endometrial	endometrial	_	_	_	_	_	_	_
23	fragments	fragment	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	survive	survive	_	_	_	_	_	_	_
26	outside	outside	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	uterine	uterine	_	_	_	_	_	_	_
29	cavity	cavity	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	investigate	investigate	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	relationship	relationship	_	_	_	_	_	_	_
6	between	between	_	_	_	_	_	_	_
7	leukocyte	leukocyte	_	_	_	_	_	_	_
8	populations	population	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	steroid	steroid	_	_	_	_	_	_	_
11	hormone	hormone	_	_	_	_	_	_	_
12	receptor	receptor	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	proliferative	proliferative	_	_	_	_	_	_	_
16	activity	activity	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	bcl-2	bcl-2	_	_	_	_	_	_	_
19	expression	expression	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	apoptosis	apoptosis	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	eutopic	eutopic	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	ectopic	ectopic	_	_	_	_	_	_	_
26	endometrium	endometrium	_	_	_	_	_	_	_
27	from	from	_	_	_	_	_	_	_
28	women	woman	_	_	_	_	_	_	_
29	with	with	_	_	_	_	_	_	_
30	endometriosis	endometriosis	_	_	_	_	_	_	_
31	or	or	_	_	_	_	_	_	_
32	adenomyosis	adenomyosis	_	_	_	_	_	_	_
33	at	at	_	_	_	_	_	_	_
34	different	different	_	_	_	_	_	_	_
35	phases	phase	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	the	the	_	_	_	_	_	_	_
38	menstrual	menstrual	_	_	_	_	_	_	_
39	cycle	cycle	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Significantly	significantly	_	_	_	_	_	_	_
2	increased	increase	_	_	_	_	_	_	_
3	oestrogen	oestrogen	_	_	_	_	_	_	_
4	receptor	receptor	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	bcl-2	bcl-2	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	numbers	number	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	CD8+	cd8+	_	_	_	_	_	_	_
13	leukocytes	leukocyte	_	_	_	_	_	_	_
14	were	be	_	_	_	_	_	_	_
15	found	find	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	ectopic	ectopic	_	_	_	_	_	_	_
18	compared	compare	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	eutopic	eutopic	_	_	_	_	_	_	_
21	endometrium	endometrium	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	endometriosis	endometriosis	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	CD56+	cd56+	_	_	_	_	_	_	_
27	endometrial	endometrial	_	_	_	_	_	_	_
28	granulated	granulate	_	_	_	_	_	_	_
29	lymphocytes	lymphocyte	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	eGLs	egl	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	were	be	_	_	_	_	_	_	_
34	significantly	significantly	_	_	_	_	_	_	_
35	reduced	reduce	_	_	_	_	_	_	_
36	in	in	_	_	_	_	_	_	_
37	ectopic	ectopic	_	_	_	_	_	_	_
38	endometrium	endometrium	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	Apoptotic	apoptotic	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	rarely	rarely	_	_	_	_	_	_	_
5	found	find	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	control	control	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	subject	subject	_	_	_	_	_	_	_
10	endometria	endometria	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	endometriosis	endometriosis	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	adenomyotic	adenomyotic	_	_	_	_	_	_	_
7	lesions	lesion	_	_	_	_	_	_	_
8	showed	show	_	_	_	_	_	_	_
9	identical	identical	_	_	_	_	_	_	_
10	steroid	steroid	_	_	_	_	_	_	_
11	hormone	hormone	_	_	_	_	_	_	_
12	receptor	receptor	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	proliferative	proliferative	_	_	_	_	_	_	_
16	activity	activity	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	bcl-2	bcl-2	_	_	_	_	_	_	_
19	expression	expression	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	leukocyte	leukocyte	_	_	_	_	_	_	_
22	subpopulations	subpopulation	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	eutopic	eutopic	_	_	_	_	_	_	_
25	endometrium	endometrium	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	indicating	indicate	_	_	_	_	_	_	_
28	different	different	_	_	_	_	_	_	_
29	aetiologies	aetiology	_	_	_	_	_	_	_
30	for	for	_	_	_	_	_	_	_
31	these	these	_	_	_	_	_	_	_
32	disorders	disorder	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	unusual	unusual	_	_	_	_	_	_	_
3	CD56+	cd56+	_	_	_	_	_	_	_
4	CD16-	cd16-	_	_	_	_	_	_	_
5	eGLs	egl	_	_	_	_	_	_	_
6	present	present	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	large	large	_	_	_	_	_	_	_
9	numbers	number	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	late	late	_	_	_	_	_	_	_
12	secretory	secretory	_	_	_	_	_	_	_
13	phase	phase	_	_	_	_	_	_	_
14	eutopic	eutopic	_	_	_	_	_	_	_
15	endometrium	endometrium	_	_	_	_	_	_	_
16	were	be	_	_	_	_	_	_	_
17	highly	highly	_	_	_	_	_	_	_
18	purified	purify	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	>98	>98	_	_	_	_	_	_	_
21	%	%	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	by	by	_	_	_	_	_	_	_
24	immunomagnetic	immunomagnetic	_	_	_	_	_	_	_
25	separation	separation	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Except	except	_	_	_	_	_	_	_
2	for	for	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	negligible	negligible	_	_	_	_	_	_	_
5	cytotoxic	cytotoxic	_	_	_	_	_	_	_
6	activity	activity	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	eGLs	egl	_	_	_	_	_	_	_
9	from	from	_	_	_	_	_	_	_
10	early	early	_	_	_	_	_	_	_
11	proliferative	proliferative	_	_	_	_	_	_	_
12	samples	sample	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	cytotoxic	cytotoxic	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	eGLs	egl	_	_	_	_	_	_	_
18	from	from	_	_	_	_	_	_	_
19	non-pregnant	non-pregnant	_	_	_	_	_	_	_
20	endometrium	endometrium	_	_	_	_	_	_	_
21	during	during	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	menstrual	menstrual	_	_	_	_	_	_	_
24	cycle	cycle	_	_	_	_	_	_	_
25	was	be	_	_	_	_	_	_	_
26	comparable	comparable	_	_	_	_	_	_	_
27	with	with	_	_	_	_	_	_	_
28	those	those	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	peripheral	peripheral	_	_	_	_	_	_	_
31	blood	blood	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	predominantly	predominantly	_	_	_	_	_	_	_
34	CD56+	cd56+	_	_	_	_	_	_	_
35	CD16+	cd16+	_	_	_	_	_	_	_
36	natural	natural	_	_	_	_	_	_	_
37	killer	killer	_	_	_	_	_	_	_
38	cells.	cells.	_	_	_	_	_	_	_
39	eGLs	egl	_	_	_	_	_	_	_
40	from	from	_	_	_	_	_	_	_
41	non-pregnant	non-pregnant	_	_	_	_	_	_	_
42	endometrium	endometrium	_	_	_	_	_	_	_
43	and	and	_	_	_	_	_	_	_
44	early	early	_	_	_	_	_	_	_
45	pregnancy	pregnancy	_	_	_	_	_	_	_
46	showed	show	_	_	_	_	_	_	_
47	a	a	_	_	_	_	_	_	_
48	variable	variable	_	_	_	_	_	_	_
49	proliferative	proliferative	_	_	_	_	_	_	_
50	response	response	_	_	_	_	_	_	_
51	to	to	_	_	_	_	_	_	_
52	5	5	_	_	_	_	_	_	_
53	and	and	_	_	_	_	_	_	_
54	100	100	_	_	_	_	_	_	_
55	U/ml	u/ml	_	_	_	_	_	_	_
56	interleukin-2	interleukin-2	_	_	_	_	_	_	_
57	over	over	_	_	_	_	_	_	_
58	48-h	48-h	_	_	_	_	_	_	_
59	and	and	_	_	_	_	_	_	_
60	120-h	120-h	_	_	_	_	_	_	_
61	time	time	_	_	_	_	_	_	_
62	courses.	courses.	_	_	_	_	_	_	_
63	eGLs	egl	_	_	_	_	_	_	_
64	are	be	_	_	_	_	_	_	_
65	evidently	evidently	_	_	_	_	_	_	_
66	functionally	functionally	_	_	_	_	_	_	_
67	important	important	_	_	_	_	_	_	_
68	in	in	_	_	_	_	_	_	_
69	the	the	_	_	_	_	_	_	_
70	eutopic	eutopic	_	_	_	_	_	_	_
71	endometrium	endometrium	_	_	_	_	_	_	_
72	.	.	_	_	_	_	_	_	_

1	Their	their	_	_	_	_	_	_	_
2	absence	absence	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	endometriotic	endometriotic	_	_	_	_	_	_	_
5	lesions	lesion	_	_	_	_	_	_	_
6	together	together	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	increased	increase	_	_	_	_	_	_	_
9	CD+8	cd+8	_	_	_	_	_	_	_
10	T-cell	t-cell	_	_	_	_	_	_	_
11	numbers	number	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	increased	increase	_	_	_	_	_	_	_
14	oestrogen	oestrogen	_	_	_	_	_	_	_
15	receptor	receptor	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	bcl-2	bcl-2	_	_	_	_	_	_	_
18	expression	expression	_	_	_	_	_	_	_
19	may	may	_	_	_	_	_	_	_
20	have	have	_	_	_	_	_	_	_
21	significant	significant	_	_	_	_	_	_	_
22	effects	effect	_	_	_	_	_	_	_
23	on	on	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	development	development	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	progression	progression	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	endometriosis	endometriosis	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

